文献速递炎症性肠病胃肠动力与功能性疾病

肠易激综合征型症状对炎症性肠病疾病活动度、医疗资源利用、心理健康和生活质量的纵向影响

Longitudinal impact of IBS-type symptoms on disease activity, healthcare utilization, psychological health, and quality of life in inflammatory bowel disease.
PubMed 文献 · Am J Gastroenterol · 2018-02-16

这项纵向研究纳入360例炎症性肠病患者,比较报告肠易激综合征型症状者与基线处于静止期、隐匿性炎症或活动期疾病者在至少2年随访中的结局。结果显示,肠易激综合征型症状与医疗资源利用增加、心理共病和生活质量降低相关,但未导致不良疾病活动结局。

要点

  • 肠易激综合征型症状患者与静止期或隐匿性炎症患者纵向疾病活动度无差异。
  • 活动期疾病患者疾病发作和医疗治疗升级风险高于肠易激综合征型症状患者(风险比(HR)=3.16;95%置信区间(CI)1.93-5.19 和 HR=3.24;95%CI 1.98-5.31)。
  • 肠易激综合征型症状患者随访时焦虑、抑郁和躯体化评分高于静止期疾病患者,生活质量评分更低。

核心结论

  • 炎症性肠病中的肠易激综合征型症状与医疗资源利用增加、心理共病和生活质量降低相关,但在延长随访期间未导致不良疾病活动结局。

研究设计与样本

  • 纵向研究,纳入360例炎症性肠病二级保健患者,比较报告肠易激综合征型症状者与基线处于静止期疾病、隐匿性炎症和活动期疾病者,随访至少2年。
  • 纵向疾病活动度由疾病发作、医疗治疗升级、住院或肠道切除定义;医疗资源利用由进行的检查数量和就诊门诊次数确定;心理幸福感和生活质量采用经验证的问卷评估。

主要发现

  • 肠易激综合征型症状患者与静止期疾病或隐匿性炎症患者之间纵向疾病活动度无差异。
  • 活动期疾病患者疾病发作和医疗治疗升级比肠易激综合征型症状患者更常见(HR=3.16;95%CI 1.93-5.19 和 HR=3.24;95%CI 1.98-5.31)。
  • 肠易激综合征型症状患者进行的检查数量多于静止期疾病患者(P=0.008),但与隐匿性炎症或活动期疾病患者相比无差异。
  • 随访时肠易激综合征型症状患者焦虑、抑郁和躯体化评分高于静止期疾病患者,生活质量评分低于静止期疾病患者,但与活动期疾病患者相似。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The impact of irritable bowel syndrome (IBS)-type symptoms on the natural history of inflammatory bowel disease (IBD) is uncertain. We aimed to address this in a longitudinal study of secondary care patients. METHODS: Longitudinal disease activity was defined by disease flare, escalation of medical therapy, hospitalization, or intestinal resection. The number of investigations performed and clinics attended determined healthcare utilization. Psychological well-being and quality of life were assessed using validated questionnaires. These outcomes were compared over a minimum period of 2 years between patients reporting IBS-type symptoms and patients with quiescent disease, occult inflammation, and active disease at baseline. RESULTS: In 360 IBD patients, there were no differences in longitudinal disease activity between patients with IBS-type symptoms and patients with quiescent disease or occult inflammation. Disease flare and escalation of medical therapy was more common in patients with active disease than in patients with IBS-type symptoms (hazard ratio (HR) = 3.16; 95% confidence interval (CI) 1.93-5.19 and HR = 3.24; 95% CI 1.98-5.31, respectively). A greater number of investigations were performed in patients with IBS-type symptoms than quiescent disease (P = 0.008), but not compared with patients with occult inflammation or active disease. Anxiety, depression, and somatization scores at follow up were higher, and quality-of-life scores lower, in patients with IBS-type symptoms when compared with patients with quiescent disease, but were similar to patients with active disease. CONCLUSIONS: IBS-type symptoms in IBD were associated with increased healthcare utilization, psychological comorbidity, reduced quality of life, but not adverse disease activity outcomes during extended follow-up.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Gracie DJ, Hamlin JP, Ford AC, et al. Longitudinal impact of IBS-type symptoms on disease activity, healthcare utilization, psychological health, and quality of life in inflammatory bowel disease. Am J Gastroenterol. 2018. PMID: 29453384. doi:10.1038/s41395-018-0021-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。